MiR-149-3p reduces polo-like kinase 1 (PLK1) expression, a crucial regulator of cell cycle progression and apoptosis, through specifically targeting its 3’UTR, leading to decreased tumor cell clonogenicity and induced apoptosis (45). Here, PLK1 is linked to neoplasm.